오믹스 랩 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 서비스별, 서비스 빈도별, 사업별, 최종사용별, 지역별, 경쟁별(2020-2030년)
Omics Lab Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Frequency Of Service, By Business, By End Use, By Region and Competition, 2020-2030F
상품코드:1714390
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
오믹스 랩 서비스 세계 시장 규모는 2024년에 725억 1,000만 달러, 2030년에는 1,246억 1,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 연평균 9.44%의 CAGR로 성장할 것으로 예상됩니다.
빠르게 발전하는 이 시장은 유전체학, 단백질체학, 대사체학, 전사체학, 후생유전학에 걸쳐 복잡한 생물학적 시스템을 이해하는 데 중요한 역할을 하고 있습니다. 이러한 서비스는 질병 진단, 바이오마커 탐색, 정밀 치료 개발을 지원합니다. 맞춤형 의료에 대한 수요 증가, 고처리 시퀀싱의 발전, 신약 개발, 농업, 환경 과학 등의 분야에서 오믹스 활용이 증가하면서 시장 성장을 견인하고 있습니다. 기술의 발전과 함께 오믹스 랩 서비스는 현대 과학 및 의료 분야에서 그 응용과 영향력을 계속 확장하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
725억 1,000만 달러
시장 규모 : 2030년
1,246억 1,000만 달러
CAGR : 2025-2030년
9.44%
급성장 부문
암
최대 시장
북미
시장 촉진요인
임상 워크플로우에 유전체학 데이터 통합 확대
주요 시장 과제
숙련된 전문가 부족
주요 시장 동향
맞춤형 의료
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 오믹스 랩 서비스 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
서비스별(유전체학, 단백질체학, 전사체학, 대사체학, 후생유전학)
서비스 빈도(일회성, 반복, 지속)
업종별(병원, 조사기관, 진단 실험실)
용도별(암, 약리학, 생식, 기타 유전성 질환) 지역별
기업별(2024년)
지역별
시장 맵
제6장 북미의 오믹스 랩 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 오믹스 랩 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 오믹스 랩 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
남
호주
제9장 남미의 오믹스 랩 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 오믹스 랩 서비스 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협/서비스
제14장 경쟁 구도
Agilent Technologies, Inc.
Q2 Solutions LLC
Flomics Biotech
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Illumina, Inc
Quest Diagnostics Incorporated
Phenoswitch Bioscience
Spectrus Corporation
BEIJING GENOMICS INSTITUTE.
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Omics Lab Services Market was valued at USD 72.51 billion in 2024 and is projected to reach USD 124.61 billion by 2030, growing at a CAGR of 9.44% during the forecast period. This rapidly advancing market spans genomics, proteomics, metabolomics, transcriptomics, and epigenetics, and plays a crucial role in understanding complex biological systems. These services support disease diagnosis, biomarker discovery, and precision treatment development. The increasing demand for personalized medicine, advancements in high-throughput sequencing, and rising use of omics in sectors such as drug discovery, agriculture, and environmental sciences are propelling market growth. As technologies evolve, omics lab services continue to expand their applications and influence in modern science and healthcare.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 72.51 Billion
Market Size 2030
USD 124.61 Billion
CAGR 2025-2030
9.44%
Fastest Growing Segment
Cancer
Largest Market
North America
Key Market Drivers
Growing Integration Of Genomics Data Into Clinical Workflows
The integration of genomics data into clinical workflows is transforming healthcare and driving significant growth in the Omics Lab Services Market. Genomic insights are reshaping disease diagnosis, risk assessment, and personalized treatment approaches. With increasing accessibility and affordability of genomic data, healthcare providers can now identify patient-specific genetic mutations and susceptibilities, allowing for more targeted and effective interventions. Technologies like high-throughput sequencing and advanced bioinformatics are streamlining the analysis and interpretation of complex datasets, making genomics integration into everyday clinical practices both feasible and beneficial. Omics service providers play a vital role in enabling this transition, delivering the analytical capabilities and expertise required to support precision medicine initiatives.
Key Market Challenges
Lack Of Skilled Professionals
A major challenge facing the Omics Lab Services Market is the shortage of skilled professionals capable of managing and interpreting complex omics data. The sector requires expertise across molecular biology, bioinformatics, and data analytics-fields where highly trained personnel are in short supply. Particularly in bioinformatics, the volume and complexity of data generated by omics platforms necessitate specialized skills in data mining, coding, and statistical analysis. This talent gap leads to data processing delays and limits the scalability of omics services. Furthermore, effective collaboration across interdisciplinary teams is essential, and the lack of professionals capable of bridging these domains impedes broader adoption and integration of omics into healthcare and research.
Key Market Trends
Personalized Medicine
Personalized medicine is a transformative trend reshaping the Omics Lab Services Market by customizing healthcare to individual genetic and molecular profiles. Omics technologies, particularly genomics and proteomics, enable healthcare providers to uncover disease markers and identify therapeutic targets unique to each patient. This is particularly impactful in oncology, where tumor-specific genetic analysis informs the selection of targeted therapies, improving outcomes and reducing adverse effects. Beyond cancer, personalized medicine is expanding into areas such as cardiology, neurology, and rare genetic disorders. The rise of direct-to-consumer genetic testing is further fueling public interest, empowering individuals to take a proactive approach to their health based on personal genetic insights.
Key Market Players
Agilent Technologies, Inc.
Q2 Solutions LLC
Flomics Biotech
QIAGEN N.V.
Thermo Fisher Scientific Inc.
Illumina, Inc
Quest Diagnostics Incorporated
Phenoswitch Bioscience
Spectrus Corporation
BEIJING GENOMICS INSTITUTE
Report Scope:
In this report, the Global Omics Lab Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Omics Lab Services Market, By Service:
Genomics
Proteomics
Transcriptomics
Metabolomics
Epigenetics
Omics Lab Services Market, By Frequency Of Service:
One-Off
Repeat
Continuous
Omics Lab Services Market, By Business:
Hospitals
Research Institutes
Diagnostic Labs
Omics Lab Services Market, By End Use:
Cancer
Pharmaco
Reproductive
Other Genetic Disease
Omics Lab Services Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Omics Lab Services Market.
Available Customizations:
Global Omics Lab Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Omics Lab Services Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenetics)
5.2.2. By Frequency Of Service (One-Off, Repeat, Continuous)
5.2.3. By Business (Hospitals, Research Institutes, Diagnostic Labs)
5.2.4. By End Use (Cancer, Pharmaco, Reproductive, Other Genetic Disease) By Region
5.2.5. By Company (2024)
5.2.6. By Region
5.3. Market Map
6. North America Omics Lab Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service
6.2.2. By Frequency of Service
6.2.3. By Business
6.2.4. By End Use
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Omics Lab Services Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Frequency of Service
6.3.1.2.3. By Business
6.3.1.2.4. By End Use
6.3.2. Canada Omics Lab Services Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Frequency of Service
6.3.2.2.3. By Business
6.3.2.2.4. By End Use
6.3.3. Mexico Omics Lab Services Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Frequency of Service
6.3.3.2.3. By Business
6.3.3.2.4. By End Use
7. Europe Omics Lab Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service
7.2.2. By Frequency of Service
7.2.3. By Business
7.2.4. By End Use
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Omics Lab Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Frequency of Service
7.3.1.2.3. By Business
7.3.1.2.4. By End Use
7.3.2. United Kingdom Omics Lab Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Frequency of Service
7.3.2.2.3. By Business
7.3.2.2.4. By End Use
7.3.3. Italy Omics Lab Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Frequency of Service
7.3.3.2.3. By Business
7.3.3.2.4. By End Use
7.3.4. France Omics Lab Services Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Frequency of Service
7.3.4.2.3. By Business
7.3.4.2.4. By End Use
7.3.5. Spain Omics Lab Services Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Frequency of Service
7.3.5.2.3. By Business
7.3.5.2.4. By End Use
8. Asia-Pacific Omics Lab Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service
8.2.2. By Frequency of Service
8.2.3. By Business
8.2.4. By End Use
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Omics Lab Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Frequency of Service
8.3.1.2.3. By Business
8.3.1.2.4. By End Use
8.3.2. India Omics Lab Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Frequency of Service
8.3.2.2.3. By Business
8.3.2.2.4. By End Use
8.3.3. Japan Omics Lab Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Frequency of Service
8.3.3.2.3. By Business
8.3.3.2.4. By End Use
8.3.4. South Omics Lab Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Frequency of Service
8.3.4.2.3. By Business
8.3.4.2.4. By End Use
8.3.5. Australia Omics Lab Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Frequency of Service
8.3.5.2.3. By Business
8.3.5.2.4. By End Use
9. South America Omics Lab Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service
9.2.2. By Frequency of Service
9.2.3. By Business
9.2.4. By End Use
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Omics Lab Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Frequency of Service
9.3.1.2.3. By Business
9.3.1.2.4. By End Use
9.3.2. Argentina Omics Lab Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Frequency of Service
9.3.2.2.3. By Business
9.3.2.2.4. By End Use
9.3.3. Colombia Omics Lab Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Frequency of Service
9.3.3.2.3. By Business
9.3.3.2.4. By End Use
10. Middle East and Africa Omics Lab Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service
10.2.2. By Frequency of Service
10.2.3. By Business
10.2.4. By End Use
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Omics Lab Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Frequency of Service
10.3.1.2.3. By Business
10.3.1.2.4. By End Use
10.3.2. Saudi Arabia Omics Lab Services Market Outlook
